The End of an Era: Shall We Move Forward?

被引：3
作者：
Dang, Chau [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 29期
关键词：
POSITIVE BREAST-CANCER; ADJUVANT TREATMENT; DOSE-DENSE; RANDOMIZED-TRIAL; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; DOCETAXEL; FLUOROURACIL; PACLITAXEL; EPIRUBICIN;
D O I：
10.1200/JCO.2011.36.7417
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3849 / 3851
页数：3
相关论文
共 23 条
[21]   Weekly paclitaxel in the adjuvant treatment of breast cancer [J].
Sparano, Joseph A. ;
Wang, Molin ;
Martino, Silvana ;
Jones, Vicky ;
Perez, Edith A. ;
Saphner, Tom ;
Wolff, Antonio C. ;
Sledge, George W., Jr. ;
Wood, William C. ;
Davidson, Nancy E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (16) :1663-1671
[22]  
Swain S, 2008, 31 ANN SAN ANT BREAS
[23]   Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer [J].
Untch, Michael ;
Moebus, Volker ;
Kuhn, Walther ;
Muck, Bernd Rudolph ;
Thomssen, Christoph ;
Bauerfeind, Ingo ;
Harbeck, Nadia ;
Werner, Christoph ;
Lebeau, Annette ;
Schneeweiss, Andreas ;
Kahlert, Stephen ;
von Koch, Franz ;
Petry, Karl Ulrich ;
Wallwiener, Diethelm ;
Kreienberg, Rolf ;
Albert, Ute-Susann ;
Lueck, Hans-Joachim ;
Hinke, Axel ;
Jaenicke, Fritz ;
Konecny, Gottfried E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :2938-2945
123